Bridging Modern Technologies With Foundational DMPK Principles to Develop Improved Therapeutics

In this 53rd Drug Metabolism GRC, conferees will be introduced to exciting new concepts and techniques in the field of microphysiological systems (MPS), learn about the latest advances regarding non-CYP enzymes and their metabolic pathways, and review cutting-edge tools and techniques that can be employed to study biotransformation. Session topics will also encompass advances in the field of drug transporters, regulation and expression of drug metabolizing enzymes, and challenges encountered regarding ADME studies to support novel therapeutic modalities. As there is a constant steam of newly marketed drugs, the potential for drug-drug interactions (DDI) continuously increases, and ensuring patient safety inevitably increases in complexity. To address this critical challenge, there will be a session focusing on DDI considerations for people at all stages of life, including how the latest advances in our field can improve therapeutic outcomes and reduce DDI risk. The Drug Metabolism GRC brings together, from academia and industry, seasoned veterans in the field, early careers scientists, postdocs, and graduate students. This diverse and enthusiastic group will share their latest data, broaden their foundational understanding of DMPK/ADME science, and make new professional connections and friendships. The program for 2025 features a wide variety of engaging sessions and speakers, providing an environment conducive to learning and advancing as researchers, with a shared goal of pushing DMPK science forward.

Please note that, due to limited accommodations at this venue, guest housing is very limited. To request family/guest housing please reach out to your Conference Operations Associate.